Effects of the Anti-CD20 Antibody Rituximab on B Cells in Human Secondary Lymphoid Organs

被引：0
|
作者：
Kamburova, E. [1 ]
Borgman, K. [1 ]
Hans, K. [1 ]
ten Berge, I [2 ]
Joosten, I [1 ]
Hilbrands, L. [3 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Lab Med, Lab Med Immunol, Nijmegen, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Nephrol, Amsterdam, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Nephrol, Nijmegen, Netherlands
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-00310
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
929
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [1] Treatment of Cutaneous Lymphoid Hyperplasia with the Monoclonal Anti-CD20 Antibody Rituximab
    Martin, Stephanie J.
    Duvic, Madeleine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (03): : 286 - 288
  • [2] Real Time Analysis of Binding between Rituximab (Anti-CD20 Antibody) and B Lymphoma Cells
    Tan, Liang
    Lin, Peiling
    Chisti, Mohammad M.
    Rehman, Abdul
    Zeng, Xiangqun
    ANALYTICAL CHEMISTRY, 2013, 85 (18) : 8543 - 8551
  • [3] BLOCKING B-CELLS (ANTI-CD20/ANTI-CD20)
    Isenberg, David A.
    RHEUMATOLOGY, 2015, 54 : 1 - 1
  • [4] Anti-CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis
    Korhonen, Riku
    Moilanen, Eeva
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 106 (01) : 13 - 21
  • [5] Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus
    Arin, MJ
    Engert, A
    Krieg, T
    Hunzelmann, N
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (03) : 620 - 625
  • [6] Successful treatment of Lymphoid granulomatosis with anti-CD20 monoclonal antibody rituximab rationale and a case report
    Jordan, Karin
    Grothe, Wilfried
    Grothey, Axel
    Kegal, Thomas
    Schmoll, Hans J.
    ANNALS OF ONCOLOGY, 2004, 15 : 158 - 158
  • [7] Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesunate
    Sieber, Sebastian
    Gdynia, Georg
    Roth, Wilfried
    Bonavida, Benjamin
    Efferth, Thomas
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (01) : 149 - 158
  • [8] Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts/microdomains of B lymphoma cells
    Semac, I
    Palomba, C
    Kulangara, K
    Klages, N
    van Echten-Deckert, G
    Borisch, B
    Hoessli, DC
    CANCER RESEARCH, 2003, 63 (02) : 534 - 540
  • [9] Rituximab, anti-CD20, inhibits a human in vivo primary and secondary antibody response to bacteriophage φX174.
    Agarwal, A
    Vieira, CA
    Book, BK
    Fineberg, NS
    Sidner, RA
    Ochs, HD
    Zeni, TM
    Benyunes, M
    Pescovitz, MD
    BLOOD, 2001, 98 (11) : 608A - 608A
  • [10] Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
    Mitchell R Smith
    Oncogene, 2003, 22 : 7359 - 7368
12345